Benign prostatic hyperplasia in older men

Clinics in Geriatric Medicine

Volumn 14, Issue 2, 1998, Pages 317-331

  Gerber, G S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; FINASTERIDE; INDORAMIN; PHENOXYBENZAMINE; PLACEBO; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMSULOSIN; TERAZOSIN;

AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; GERIATRIC PATIENT; HUMAN; HYPERTHERMIC THERAPY; IMPOTENCE; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PROSTATE DISEASE; PROSTATE HYPERTROPHY; REVIEW; TRANSURETHRAL RESECTION; TREATMENT INDICATION; VERTIGO;

EID: 0031949304     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0749-0690(18)30120-4     Document Type: Review

References (63)

1. P. Abrams Objective evaluation of bladder outlet obstruction Br J Urol 76 1995 11
2. P. Abrams R.C.L. Fenely The significance of the symptoms associated with bladder outflow obstruction Urol Int 33 1978 171
3. P. Abrams C.C. Schulman S. Vaage European Tamsulosin Study Group: Tamsulosin, a selective alpha-1 c adrenoceptor antagonist, a randomized, controlled trial in patients with benign prostatic obstruction (symptomatic BPH) Br J Urol 76 1995 325
4. S. Baba K. Nakamura M. Tachibana Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: Durability of response Urology 47 1996 664
5. M.J. Barry F.J. Fowler Jr. L. Bin The natural history of patients with benign prostatic hyperplasia diagnosed by North American urologists J Urol 157 1997 10
6. M.J. Barry F.J. Fowler Jr. M.P. O’Leary Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen. Boyarsky, and Maine Medical Assessment Program symptom indexes Measurement Committee of the American Urological Association J Urol 148 1993 1558
7. M.J. Barry F.J. Fowler Jr. M.P. O’Leary The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1992 1549
8. S.J. Barry D.S. Coffey P.C. Walsh The development of human benign prostatic hyperplasia with age J Urol 132 1984 474
9. N.C. Birch G. Hurst P.T. Doyle Serial residual volumes in men with prostatic hypertrophy Br J Urol 62 1988 571
10. M. Caine Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy Urology 32 1988 16
11. M. Caine S. Tarlberg S. Meretyk A placebo controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction Br J Urol 50 1978 551
12. M. Caine S. Raz M. Ziegler Adrenergic and cholinergic receptors in the human prostate, prostate capsule, and bladder neck Br J Urol 50 1975 551
13. M.B. Chancellor J.G. Blaivas S.A. Kaplan Bladder outlet obstruction versus impaired detrusor contractility: The role of uroflow J Urol 145 1993 310
14. The Department of Veterans Affairs Cooperative Study of Transurethral Resection for Benign Prostatic Hyperplasia:, A., comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic, hyperplasia J., Urol 150 1993 1696
15. de Wildt MJAM, Debruyne FMJ, de la Rosette JJMCH: High-energy transurethral microwave thermotherapy: A thermoablative treatment for benign prostatic obstruction Urology 48 1996 416
16. A.C. Diokno M.B. Brown N.G. Goldstein Urinary flow rates and voiding pressures in elderly men living in a community J Urol 151 1994 1550
17. A. Fawzy K. Braun G.P. Lewis Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: A multicenter study J Urol 154 1995 105
18. Finasteride Study Group: Finasteride (MK-906) in the treatment of benign prostatic, hyperplasia Prostate 22 1993 291
19. P.C. Frimodt-Moller K.M.E. Jensen P. Iversen Analysis of presenting symptoms in prostatism J Urol 132 1984 272
20. W.F. Gee H.L. Holtgrewe P.C. Albertsen Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States J Urol 154 1995 205
21. G.S. Gerber Lasers in the treatment of benign prostatic hyperplasia Urology 45 1995 193
22. G.S. Gerber The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia Urology 48 1996 668
23. S. Gerber B.A. Contreras G.P. Zagaja Doxazosin in men with lower urinary tract symptoms: Urodynamic evaluation at 15 months Urology 50 1997 229
24. G.S. Gerber E.R. Goldfischer T.G. Karrison Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia Urology 49 1997 697
25. G.S. Gerber J.H. Kim B.A. Contreras An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin Urology 47 1996 840
26. T.G. Gerstenberg J.T. Andersen P. Klarkskov High flow intravesical obstruction in men Symptomatology, urodynamics and the results of surgery J. Urol 127 1982 943
27. J.Y. Gillenwater R.L. Conn S.G. Chrysant Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate hypertension: A double-blind, placebo-controlled, dose-response multicenter study J Urol 154 1995 110
28. G.J. Gormley E. Stoner R.C. Bmskewitz The effect of finasteride in men with benign prostatic hyperplasia N Engl J Med 327 1992 1185
29. H.A. Guess J.F. Heyse G.J. Gormley The effect of finasteride on prostatic specific antigen in men with benign prostatic hyperplasia Prostate 22 1993 31
30. J.B. Hollander A.C. Diokno Prostatism. Benign prostatic hyperplasia Urol Clin North Am 23 1996 75
31. M.M. Issa Transurethral needle ablation of the prostate: Report of initial United States clinical trial J Urol 156 1996 413
32. K.M.E. Jensen R.C. Bruskawitz P. Iversen Predictive value of voiding pressures in benign prostatic hyperplasia Neurourol Urodyn 2 1983 117
33. K.M.E. Jensen J.B. Jorgensen P. Mogensen Reproducibility of uroflowmetry variables in elderly males Urol Res 13 1985 237
34. K.M.E. Jensen J.B. Jorgensen P. Mogensen Relationship between urinary flow curve patterns and symptomatology in elderly males Scand J Urol Nephrol 104 1987 69
35. K.M.E. Jensen J.B. Jorgensen P. Mogensen Urodynamics in prostatism, I. Prognostic value of uroflowmetry. Scand J Urol Nephrol 22 1988 109
36. J.B. Jorgensen K.M.E. Jensen N.E. Bille-Brahe Uroflowmetry in asymptomatic elderly males Br J Urol 58 1986 390
37. S.A. Kaplan D.L. Bowers A.E. Te Differential diagnosis of prostatism: A 12-year retrospective analysis of symptoms, urodynamics and satisfaction with therapy J Urol 155 1996 1303
38. S.A. Kaplan A.E. Te Transurethral electro vaporization of the prostate: A novel method for treating men with benign prostatic hyperplasia Urology 45 1995 566
39. D.S.C. Ko H.N. Fenster K. Chambers The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasia J Urol 154 1995 396
40. G.E. Leach L. Sirls K. Ganabathi Outpatient visual laser-assisted prostatectomy under local anesthesia Urology 43 1994 149
41. H. Lepor Long-term safety and effectiveness of terazosin in patients with benign prostatic hyperplasia Urology 45 1995 406
42. H. Lepor S. Auerbach A. Puras-Baez A randomized multicenter placebo controlled study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia J Urol 148 1992 1467
43. H. Lepor F. Machi Comparison of the AUA symptom index in unselected males and females between 55 and 79 years of age Urology 42 1993 36
44. H. Lepor W.O. Williford M.J. Barry The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia N Engl J Med 335 1996 533
45. H. Matzkin A. Greenstein T. Prager-Geller Do reported micturition symptoms on the American Urological Association questionnaire correlate with 24-hour home uroflowmetry recordings? J Urol 155 1996 197
46. H. Matzkin R. van der Zwaag Y. Chen How reliable is a single measurement of urinary flow in the diagnosis of obstruction in benign prostatic hyperplasia Br J Urol 72 1993 181
47. J. McConnell K. Akakura G. Bartsch Hormonal treatment of benign prostatic hyperplasia A.T.K. Cockett S. Khoury Y. Aso The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH) (Proceedings 2) 1993 Scientific Communications International Paris 417 June
48. J.D. McConnell M.J. Barry R.C. Bruskewitz Benign Prostatic Hyperplasia: Diagnosis and Treatment. Quick Reference Guide for Clinicians. AHCPR Publication No. 94-0583. Rockville MD, Agency for Health Care Policy and Research 1994 Department of Health and Human Services Public Health Service, US February
49. J. McNeal Pathology of benign prostatic hyperplasia: Insight into etiology Urol Clin North Am 17 1990 477
50. W.K. Mebust H.L. Holtgrewe A.T.K. Cockett Transurethral prostatectomy: Immediate and postoperative complications: A cooperative study of 13 participating institutions evaluating 3885 patients J Urol 141 1989 243
51. M.C. Michel B.A. Kenny D.A. Schwinn Classification of alpha-1 adrenoceptor subtypes Naunyn-Schmiedebergs Arch Pharmacol 352 1995 1
52. N.R. Netto Jr. C.A.L. D’ancona M.L. de Lima Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia J Urol 155 1996 200
53. J.E. Oesterling Benign prostatic hyperplasia. Medical and minimally invasive treatment options N Engl J Med 332 1995 99 109
54. A.L. Poulsen J. Schou L. Puggaard Prostatic enlargement, symptomatology and pressure/flow evaluation: Interrelations in patients with symptomatic BPH Scand J Urol Nephrol 157 1993 67
55. R.S. Rittmaster Finasteride N Engl J Med 330 1994 120
56. H.J. Rollema R. van Mastrigt Improved indication and follow-up in transurethral resection of the prostate using the computer program CLIM. A prospective study J Urol 148 1992 111
57. S.H. Sacks S.A.J.R. Aparicio A. Bevan Late renal failure due to prostatic outflow obstruction: A preventable disease Br M ed J 298 1989 156
58. W. Schafer H. Rubben R. Noppeney Obstructed and unobstructed prostatic obstruction. A plea for urodynamic objectivation of bladder outflow obstruction in benign prostatic hyperplasia World J Urol 6 1989 198
59. M.B. Siroky C.A. Olsson R.J. Krane The flow rate nomogram: II Clinical correlation J Urol 123 1980 208
60. D.S. Smith W.J. Catalona The nature of prostate cancer detected through prostate specific antigen based screening J Urol 152 1994 1732
61. W.P.J. Witjes P.F.W.M. Rosier J.A.M. de Wildt Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia J Urol 155 1996 1317
62. S.H. Woolf Public health perspective: The health policy implications of screening for prostate cancer J Urol 152 1994 1685
63. S.V. Yalla M.P. Sullivan H.S. Lacanwasam Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism J Urol 153 1995 674